Categories AlphaGraphs, Cannabis, Earnings
ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues
Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter.
The Canada-based recreational marijuana company reported a net loss from continuing operations of C$20.8 million for the fourth quarter, compared to a loss of C$76.2 million in the prior-year period. Adjusted EBITDA was C$1.89 million during the three months, down 5% from the year-ago quarter. Total revenues increased 5% annually to C$67.4 million in Q4.
“Aurora is the largest global medical cannabis company in nationally legal markets and our leadership is best differentiated by serving the diverse needs of patients across the world. In Q4 2024, global medical cannabis net revenue1 increased 20% year-over-year, supported by the recent acquisition of MedReleaf Australia, where we saw significant growth, along with higher sales in Poland and the UK,” said Aurora’s CEO Miguel Martin.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
McCormick & Company (MKC) Q2 2024 Earnings: Key financials and quarterly highlights
McCormick & Company, Incorporated (NYSE: MKC) reported second quarter 2024 earnings results today. Net sales decreased 1% year-over-year to $1.64 billion. Sales declined 1% in constant currency as well. Net income
Micron (MU) Q3 2024 profit exceeds expectations; revenue up 82%
Micron Technology Inc. (NASDAQ: MU) reported a sharp increase in revenues for the third quarter of 2024, and the chipmaker turned to a profit from a loss last year. The
Important takeaways from FedEx Corporation’s (FDX) Q4 2024 earnings report
FedEx Corporation (NYSE: FDX) this week reported better-than-expected fourth-quarter numbers and raised its FY25 earnings guidance, triggering a stock rally that drove up FDX to a three-year high. Reflecting the